NCT02710370View on ClinicalTrials.gov

Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

Active, not recruitingOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions
ObesityDiabetes Mellitus, Type 2Endocrine System DiseasesGlucose Metabolism DisordersMetabolic Diseases
Trial Locations (1)

15213

Magee-Womens Hospital of UPMC, Pittsburgh

All Listed Sponsors
collaborator

Harvard University

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Pittsburgh

OTHER